LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company developing checkpoint modulator antibodies and cancer vaccines, today announced participation at the following conferences:
• The 6th Annual William Blair and Maidstone Life Sciences conference “Cancer Immunotherapy: A Long-Awaited Reality Conference” at the Apella, Event Space Alexandria Center in New York, NY on Thursday, March 31, 2016. Robert B. Stein, M.D., Ph.D., President, R&D will moderate three panels and present at a session titled “Integrated Approach to Optimizing Cancer Immunotherapy.”
